When the Norwegian and UK Rituximab trials start publishing results in 2-3 years time and if these results are as positive as their previous studies will this be enough to force insurance companies here in the U.S. to pay for the intervention? Also i don't know if anyone has thought of this but a year's worth of Rituximab is cheaper than a year's worth of Valcyte. And most people have had no trouble getting insurance companies to pay for Valcyte (including myself, in fact the insurance company didn't consider it at all special a required no approval at all). If you look at GoodRx.com a month's worth of Valcyte @ 3 x 450mg / day ~ $4000 / month ~ $48,000 / year! That's more than a year's worth of Rituximab @ 6 infusions / year so I don't get why insurance won't cover it off-label if your physician prescribes it today?